Latest Commercialisation News

Sparc Technologies has secured a $680,000 non-dilutive advance on its anticipated FY26 R&D tax refund, strengthening its cash flow as it accelerates commercialisation of its graphene additive ecosparc and green hydrogen ventures.

Brazilian Rare Earths Limited has secured a key Trial Mining Licence for its Monte Alto project, marking a significant step toward commercial rare earths production in Brazil.

Clarity Pharmaceuticals has signed a significant manufacturing supply agreement with Theragenics to produce copper-64, a key isotope for its upcoming prostate cancer diagnostic, Cu-SAR-bisPSMA. This deal strengthens Clarity’s US supply network ahead of anticipated FDA approval and commercial launch.

Nanoveu Limited showcased its cutting-edge EMASS semiconductor technology at the Pitt Street Research Semiconductor Conference 2026, spotlighting its ultra-low-power AI chips designed for next-gen smart devices and drones.

Recce Pharmaceuticals has expanded its intellectual property footprint with a newly granted patent in Brazil, protecting its innovative synthetic anti-infectives against a broad range of infections. This milestone strengthens Recce’s position in one of South America’s largest antibiotic markets.

H3 Energy Limited is launching a detailed assessment of helium and hydrogen potential at its Milford and Milford East structures, aiming to unlock high-value gas resources in the underexplored Officer Basin.

Sparc Technologies has formalised a collaboration with HydroGraph Clean Power to test and potentially commercialise graphene-enhanced additives for protective coatings, aiming to revolutionise corrosion protection.

Green360 Technologies has inked a binding toll treatment agreement with Calix Limited to commercially produce Eco-Clay, a low-carbon cement replacement, marking a key step toward scaling sustainable concrete solutions in Australia.

Energy Technologies Limited, via its subsidiary Cogenic, has acquired Maradin Ltd’s laser optical engineering IP portfolio, positioning itself at the forefront of laser projection technology for AR, VR, and defence applications.

Cleo Diagnostics has expanded its ovarian cancer biomarker panel from five to eight markers, enhancing test reliability and gearing up for FDA submission. A manufacturing deal is imminent, setting the stage for commercial rollout.

Pantera Minerals spotlights the launch of EnergyX’s Lonestar lithium demonstration plant in Texas, marking a key step towards a 50,000 tonne per annum lithium production target in the US.

Alligator Energy has initiated uranium extraction at its Samphire Uranium Project, marking a key milestone as initial uranium concentrations are detected during the Field Recovery Trial.